Type I reaction in a borderline leprosy case successfully treated with multidrug therapy and ofloxacin.
Asz-Sigall
Daniel
D
López-García
Lirio
L
Neme-Yunes
Yvette
Y
Yuen-Palos
Ricardo
R
Vega-Memije
Maria Elisa
ME
Arenas
Roberto
R
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002991:Clofazimine / Q000627:therapeutic use; D003622:Dapsone / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007917:Leprostatic Agents / Q000627:therapeutic use*; D015439:Leprosy, Borderline / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D015242:Ofloxacin / Q000627:therapeutic use*; D011241:Prednisone / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D005938:Glucocorticoids; D007917:Leprostatic Agents; D003622:Dapsone; D015242:Ofloxacin; D002991:Clofazimine; D011241:Prednisone; D012293:Rifampin